BioSig Technologies, Inc. (BSGM)
USD 0.51
(-3.33%)
USD 0.51
(-3.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 28.53 Million USD | 3.77% |
| 2022 | 27.49 Million USD | -18.3% |
| 2021 | 33.65 Million USD | -43.14% |
| 2020 | 59.18 Million USD | 71.03% |
| 2019 | 34.6 Million USD | 100.46% |
| 2018 | 17.26 Million USD | 33.75% |
| 2017 | 12.9 Million USD | 15.6% |
| 2016 | 11.16 Million USD | -7.3% |
| 2015 | 12.04 Million USD | 53.07% |
| 2014 | 7.86 Million USD | 26.12% |
| 2013 | 6.23 Million USD | 175.8% |
| 2012 | 2.26 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.3 Million USD | 70.03% |
| 2024 Q1 | 3.12 Million USD | -49.51% |
| 2023 FY | 28.53 Million USD | 3.77% |
| 2023 Q2 | 10.9 Million USD | 47.58% |
| 2023 Q3 | 4.05 Million USD | -62.85% |
| 2023 Q4 | 6.17 Million USD | 52.49% |
| 2023 Q1 | 7.39 Million USD | 4.01% |
| 2022 Q2 | 5.72 Million USD | -29.1% |
| 2022 Q1 | 8.07 Million USD | -10.37% |
| 2022 Q4 | 7.1 Million USD | 7.81% |
| 2022 Q3 | 6.59 Million USD | 15.15% |
| 2022 FY | 27.49 Million USD | -18.3% |
| 2021 Q2 | 8.19 Million USD | -4.46% |
| 2021 FY | 33.65 Million USD | -43.14% |
| 2021 Q3 | 7.87 Million USD | -3.97% |
| 2021 Q4 | 9 Million USD | 14.43% |
| 2021 Q1 | 8.57 Million USD | -21.53% |
| 2020 Q1 | 12.8 Million USD | -15.97% |
| 2020 FY | 59.18 Million USD | 71.03% |
| 2020 Q3 | 13.1 Million USD | -41.38% |
| 2020 Q2 | 22.34 Million USD | 74.56% |
| 2020 Q4 | 10.93 Million USD | -16.55% |
| 2019 FY | 34.6 Million USD | 100.46% |
| 2019 Q1 | 5.87 Million USD | 2.99% |
| 2019 Q2 | 7.98 Million USD | 35.96% |
| 2019 Q3 | 5.5 Million USD | -31.11% |
| 2019 Q4 | 15.23 Million USD | 176.85% |
| 2018 FY | 17.26 Million USD | 33.75% |
| 2018 Q4 | 5.7 Million USD | 80.95% |
| 2018 Q3 | 3.15 Million USD | -45.33% |
| 2018 Q2 | 5.76 Million USD | 118.69% |
| 2018 Q1 | 2.63 Million USD | -48.03% |
| 2017 Q1 | 2.89 Million USD | 64.82% |
| 2017 FY | 12.9 Million USD | 15.6% |
| 2017 Q3 | 1.91 Million USD | -36.58% |
| 2017 Q4 | 5.07 Million USD | 165.09% |
| 2017 Q2 | 3.01 Million USD | 4.12% |
| 2016 Q1 | 2.31 Million USD | 10.84% |
| 2016 Q4 | 1.75 Million USD | 13.12% |
| 2016 Q3 | 1.55 Million USD | -71.91% |
| 2016 Q2 | 5.53 Million USD | 139.19% |
| 2016 FY | 11.16 Million USD | -7.3% |
| 2015 Q2 | 4.43 Million USD | 45.16% |
| 2015 FY | 12.04 Million USD | 53.07% |
| 2015 Q1 | 3.05 Million USD | 17.05% |
| 2015 Q4 | 2.08 Million USD | -15.6% |
| 2015 Q3 | 2.47 Million USD | -44.15% |
| 2014 Q4 | 2.6 Million USD | -33.9% |
| 2014 FY | 7.86 Million USD | 26.12% |
| 2014 Q1 | 728.15 Thousand USD | -17.31% |
| 2014 Q2 | 588.52 Thousand USD | -19.17% |
| 2014 Q3 | 3.94 Million USD | 570.21% |
| 2013 Q1 | 3.68 Million USD | 413.81% |
| 2013 FY | 6.23 Million USD | 175.8% |
| 2013 Q3 | 803.72 Thousand USD | -34.38% |
| 2013 Q2 | 1.22 Million USD | -66.81% |
| 2013 Q4 | 880.56 Thousand USD | 9.56% |
| 2012 FY | 2.26 Million USD | 0.0% |
| 2012 Q4 | 718.16 Thousand USD | 8.28% |
| 2012 Q3 | 663.24 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -154.187% |
| Cerus Corporation | 143.15 Million USD | 80.071% |
| OrthoPediatrics Corp. | 137.01 Million USD | 79.178% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -151.125% |
| Talis Biomedical Corporation | 67.18 Million USD | 57.536% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -14.367% |
| Inogen, Inc. | 236.08 Million USD | 87.915% |
| Spectral AI, Inc. | 20.86 Million USD | -36.743% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 49.051% |
| CVRx, Inc. | 76.14 Million USD | 62.531% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -708.674% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -128.441% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.725% |
| Venus Concept Inc. | 80.47 Million USD | 64.548% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 49.574% |
| Bioventus Inc. | 409.91 Million USD | 93.04% |
| BrainsWay Ltd. | 28.01 Million USD | -1.827% |
| Envoy Medical, Inc. | 17.89 Million USD | -59.403% |
| electroCore, Inc. | 32.03 Million USD | 10.93% |
| IceCure Medical Ltd | 16.87 Million USD | -69.057% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 32.763% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -61.799% |
| MaxCyte, Inc. | 84.84 Million USD | 66.374% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -129.863% |
| Nexalin Technology, Inc. | 5.78 Million USD | -393.483% |
| PAVmed Inc | 64.82 Million USD | 55.991% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 44.144% |
| RxSight, Inc. | 103.85 Million USD | 72.528% |
| Sight Sciences, Inc. | 126.44 Million USD | 77.438% |
| SI-BONE, Inc. | 156.35 Million USD | 81.753% |
| TELA Bio, Inc. | 84.18 Million USD | 66.111% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 59.275% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 85.971% |
| LivaNova PLC | 843.54 Million USD | 96.618% |
| 908 Devices Inc. | 68.08 Million USD | 58.093% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 94.1% |
| Nemaura Medical Inc. | 7.13 Million USD | -299.647% |
| NeuroPace, Inc. | 75.29 Million USD | 62.11% |
| LENSAR, Inc. | 33.33 Million USD | 14.417% |
| Apyx Medical Corporation | 51.01 Million USD | 44.079% |
| Cutera, Inc. | 197.72 Million USD | 85.571% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -15.129% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 85.1% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 20.882% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.589% |
| Axonics, Inc. | 270.2 Million USD | 89.441% |
| Outset Medical, Inc. | 198.77 Million USD | 85.647% |
| IRIDEX Corporation | 31.81 Million USD | 10.322% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 84.169% |
| IRadimed Corporation | 30.12 Million USD | 5.288% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -234.388% |
| INVO Bioscience, Inc. | 7.85 Million USD | -263.287% |
| Telesis Bio, Inc. | 63.48 Million USD | 55.063% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 71.022% |
| Varex Imaging Corporation | 224.8 Million USD | 87.309% |
| Quipt Home Medical Corp. | 148.66 Million USD | 80.809% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -143.368% |
| Pulmonx Corporation | 112.68 Million USD | 74.682% |
| Dynatronics Corporation | 9.9 Million USD | -187.948% |
| Modular Medical, Inc. | 17.52 Million USD | -62.759% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -41.329% |
| Semler Scientific, Inc. | 38.94 Million USD | 26.741% |
| InMode Ltd. | 215.68 Million USD | 86.772% |
| Bruker Corporation | 1.07 Billion USD | 97.349% |
| Cytosorbents Corporation | 48.33 Million USD | 40.977% |
| DexCom, Inc. | 1.69 Billion USD | 98.313% |
| Align Technology, Inc. | 2.07 Billion USD | 98.626% |
| Viveve Medical, Inc. | 22.17 Million USD | -28.67% |
| ZimVie Inc. | 275.12 Million USD | 89.63% |
| Movano Inc. | 29.69 Million USD | 3.907% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 79.216% |
| Nexalin Technology, Inc. | 5.78 Million USD | -393.483% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -708.674% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.252% |
| Profound Medical Corp. | 33.6 Million USD | 15.097% |
| Insulet Corporation | 939.9 Million USD | 96.965% |
| enVVeno Medical Corporation | 25.23 Million USD | -13.044% |
| Surmodics, Inc. | 98.69 Million USD | 71.093% |
| iCAD, Inc. | 22.22 Million USD | -28.369% |
| Nuwellis, Inc. | 22.61 Million USD | -26.166% |
| Biotricity, Inc. | 17.18 Million USD | -66.021% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 93.602% |
| Aethlon Medical, Inc. | 12.27 Million USD | -132.376% |
| InspireMD, Inc. | 22.95 Million USD | -24.314% |
| PAVmed Inc. | 64.82 Million USD | 55.991% |
| BIOLASE, Inc. | 34.66 Million USD | 17.688% |
| Beyond Air, Inc. | 61.7 Million USD | 53.76% |
| FONAR Corporation | 28.6 Million USD | 0.261% |
| AxoGen, Inc. | 149.33 Million USD | 80.895% |
| Vivani Medical, Inc. | 26.96 Million USD | -5.804% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 83.89% |
| Inari Medical, Inc. | 448.59 Million USD | 93.64% |
| UFP Technologies, Inc. | 58.08 Million USD | 50.886% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -478.984% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -351.546% |
| Tenon Medical, Inc. | 16.96 Million USD | -68.14% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -285.906% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 35.31% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.353% |
| Sintx Technologies, Inc. | 15.2 Million USD | -87.685% |
| NanoVibronix, Inc. | 4.97 Million USD | -473.698% |
| Quanterix Corporation | 118.1 Million USD | 75.843% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -143.368% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -97.549% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 92.734% |
| TransMedics Group, Inc. | 182.82 Million USD | 84.394% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -1.657% |
| NeuroMetrix, Inc. | 11.09 Million USD | -157.052% |
| Hyperfine, Inc. | 52.87 Million USD | 46.039% |
| Establishment Labs Holdings Inc. | 172 Million USD | 83.413% |
| Biomerica, Inc. | 6.97 Million USD | -308.856% |
| Bone Biologics Corporation | 9.42 Million USD | -202.6% |
| AVITA Medical, Inc. | 80.77 Million USD | 64.682% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -176.689% |
| Silk Road Medical, Inc | 186.35 Million USD | 84.691% |